Viewing Study NCT02673606


Ignite Creation Date: 2025-12-26 @ 5:20 PM
Ignite Modification Date: 2026-01-01 @ 12:41 AM
Study NCT ID: NCT02673606
Status: COMPLETED
Last Update Posted: 2020-07-30
First Post: 2016-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of Estrogen on Fear Extinction R61
Sponsor: NYU Langone Health
Organization:

Study Overview

Official Title: The Influence of Estrogen on the Fear Extinction Network in Humans-R61
Status: COMPLETED
Status Verified Date: 2020-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this project is to examine how estrogen may influence the resting-state connectivity and the extinction-induced activation of the fear extinction network.
Detailed Description: The aim of the study was to examine the influence of exogenous estrogen administration on the activation of the fear extinction network in women. Functional MRI data and psychophysiological indices were collected to test the influence of estrogen on women's ability to regulate conditioned fear responses. Women underwent a 3 day experimental paradigm using classical fear conditioning. The first day was conducted outside the scanner, while days 2 and 3 were done inside the fMRI scanner and tested fear extinction learning and recall in days 2 and 3, respectively. The estrogen (or placebo) pill was given just hours before extinction learning test on day 2. No followups were conducted after women completed the 3 day study.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: